Name | Byakangelicin |
---|---|
Synonyms |
7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-
9-[(2R)-2,3-Dihydroxy-3-methylbutoxy]-4-methoxy-7H-furo[3,2-g]chromen-7-one |
Description | Byakangelicin, one of the active compounds found in the roots of Angelica gigas, can serve as a modulator to improve brain accumulation of diverse active compounds (Umb, Cur, and Dox) and enhance therapeutic effects[1]. Byakangelicin is likely to increase the expression of all PXR target genes (such as MDR1) and induce a wide range of drug-drug interactions. Byakangelicin can inhibit the effects of sex hormones, it may increase the catabolism of endogenous hormones[2]. |
---|---|
Related Catalog | |
Target |
PXR[2] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 571.5±50.0 °C at 760 mmHg |
Melting Point | 123-124℃ |
Molecular Formula | C17H18O7 |
Molecular Weight | 334.321 |
Flash Point | 299.4±30.1 °C |
Exact Mass | 334.105255 |
PSA | 102.27000 |
LogP | 1.62 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.613 |
Storage condition | ?20°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Phrases | 22-36/37/38 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |